These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20963816)

  • 1. Test-retest variability of [¹¹C]raclopride-binding potential in nontreatment-seeking alcoholics.
    Yoder KK; Albrecht DS; Kareken DA; Federici LM; Perry KM; Patton EA; Zheng QH; Mock BH; O'Connor S; Herring CM
    Synapse; 2011 Jul; 65(7):553-61. PubMed ID: 20963816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term test-retest reliability of striatal and extrastriatal dopamine D2/3 receptor binding: study with [(11)C]raclopride and high-resolution PET.
    Alakurtti K; Johansson JJ; Joutsa J; Laine M; Bäckman L; Nyberg L; Rinne JO
    J Cereb Blood Flow Metab; 2015 Jul; 35(7):1199-205. PubMed ID: 25853904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride.
    Kodaka F; Ito H; Kimura Y; Fujie S; Takano H; Fujiwara H; Sasaki T; Nakayama K; Halldin C; Farde L; Suhara T
    Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):574-9. PubMed ID: 23238524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
    Kim JS; Ichise M; Sangare J; Innis RB
    J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of striatal and thalamic dopamine D2 receptor binding using [11C]raclopride with high-resolution positron emission tomography.
    Alakurtti K; Aalto S; Johansson JJ; Någren K; Tuokkola T; Oikonen V; Laine M; Rinne JO
    J Cereb Blood Flow Metab; 2011 Jan; 31(1):155-65. PubMed ID: 20442726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of striatal [¹¹C]raclopride binding in smokers wearing transdermal nicotine patches.
    Yoder KK; Albrecht DS; Kareken DA; Federici LM; Perry KM; Patton EA; Zheng QH; Mock BH; O'Connor SJ; Herring CM
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):220-5. PubMed ID: 22009382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in IV alcohol-induced dopamine release in the ventral striatum of social drinkers and nontreatment-seeking alcoholics.
    Yoder KK; Albrecht DS; Dzemidzic M; Normandin MD; Federici LM; Graves T; Herring CM; Hile KL; Walters JW; Liang T; Plawecki MH; O'Connor S; Kareken DA
    Drug Alcohol Depend; 2016 Mar; 160():163-9. PubMed ID: 26832934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monetary discounting and ventral striatal dopamine receptor availability in nontreatment-seeking alcoholics and social drinkers.
    Oberlin BG; Albrecht DS; Herring CM; Walters JW; Hile KL; Kareken DA; Yoder KK
    Psychopharmacology (Berl); 2015 Jun; 232(12):2207-16. PubMed ID: 25563235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride.
    Hirvonen J; Aalto S; Lumme V; Någren K; Kajander J; Vilkman H; Hagelberg N; Oikonen V; Hietala J
    Nucl Med Commun; 2003 Dec; 24(12):1207-14. PubMed ID: 14627846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C]raclopride.
    Kim JH; Son YD; Kim HK; Lee SY; Cho SE; Kim YB; Cho ZH
    J Clin Psychopharmacol; 2011 Aug; 31(4):507-11. PubMed ID: 21694619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low convergent validity of [
    Freiburghaus T; Svensson JE; Matheson GJ; Plavén-Sigray P; Lundberg J; Farde L; Cervenka S
    Neuroimage; 2021 Feb; 226():117523. PubMed ID: 33144221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic Modelling and Test-Retest Reproducibility for the Dopamine D
    Bertoglio D; Verhaeghe J; Miranda A; Wyffels L; Stroobants S; Dominguez C; Munoz-Sanjuan I; Skinbjerg M; Liu L; Staelens S
    Mol Imaging Biol; 2021 Apr; 23(2):208-219. PubMed ID: 33179158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation of changes in binding potential with a simplified reference tissue model and multiple injections of [11C]raclopride.
    Ikoma Y; Watabe H; Hayashi T; Miyake Y; Teramoto N; Minato K; Iida H
    Neuroimage; 2009 Oct; 47(4):1639-48. PubMed ID: 19520172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride.
    Constantinescu CC; Coleman RA; Pan ML; Mukherjee J
    Synapse; 2011 Aug; 65(8):778-87. PubMed ID: 21218455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High long-term test-retest reliability for extrastriatal
    Karalija N; Jonassson L; Johansson J; Papenberg G; Salami A; Andersson M; Riklund K; Nyberg L; Boraxbekk CJ
    J Cereb Blood Flow Metab; 2020 Sep; 40(9):1859-1868. PubMed ID: 31506011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.
    Egerton A; Ahmad R; Hirani E; Grasby PM
    Psychopharmacology (Berl); 2008 Nov; 200(4):487-96. PubMed ID: 18597077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and implementation of an automated partial volume correction in PET: application to dopamine receptor quantification in the normal human striatum.
    Rousset OG; Collins DL; Rahmim A; Wong DF
    J Nucl Med; 2008 Jul; 49(7):1097-106. PubMed ID: 18552147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test-retest stability of cerebral mGluR₅ quantification using [¹¹C]ABP688 and positron emission tomography in rats.
    Elmenhorst D; Aliaga A; Bauer A; Rosa-Neto P
    Synapse; 2012 Jun; 66(6):552-60. PubMed ID: 22290765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.
    Hirvonen J; Karlsson H; Kajander J; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
    Psychopharmacology (Berl); 2008 May; 197(4):581-90. PubMed ID: 18251011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.